BIOREGENX, INC. Research and Development Expense
BIOREGENX, INC. (BRGX) reported Research and Development Expense of $31.75 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-15
- BIOREGENX, INC. research and development expense for the quarter ending 2025-12-31 was $31.75K.
- BIOREGENX, INC. research and development expense for the quarter ending 2025-09-30 was $0.00.
- BIOREGENX, INC. research and development expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOREGENX, INC. research and development expense for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOREGENX, INC. research and development expense for fiscal 2025 was $31.75K.
- BIOREGENX, INC. research and development expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BIOREGENX, INC. research and development expense for fiscal 2023 was $257.72K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $31.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $31.75K derived: sum of 2 quarters · filed 2026-04-15 | $31.75K derived: sum of 3 quarters · filed 2026-04-15 | $31.75K 10-K · filed 2026-04-15 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | -$14.54K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | -$14.54K derived: sum of 3 quarters · filed 2026-04-15 | -$14.54K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | -$14.54K derived: sum of 2 quarters · filed 2026-04-15 | -$14.54K derived: sum of 3 quarters · filed 2026-04-15 | -$7.04K derived: sum of 4 quarters · filed 2026-04-15 |
| 2024-12-31 | -$14.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$14.54K derived: sum of 2 quarters · filed 2026-04-15 | -$7.04K derived: sum of 3 quarters · filed 2026-04-15 | $0.00 10-K · filed 2026-04-15 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $7.50K derived: sum of 2 quarters · filed 2025-11-14 | $14.54K 10-Q · filed 2025-11-14 | $115.69K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $7.50K 10-Q · filed 2025-08-14 | $35.81K 10-Q · filed 2025-08-14 | $115.69K derived: sum of 3 quarters · filed 2025-08-14 | $196.47K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $25.54K 10-Q · filed 2025-05-15 | $108.19K derived: sum of 2 quarters · filed 2025-05-15 | $188.97K derived: sum of 3 quarters · filed 2025-05-15 | $269.75K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $82.65K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $163.43K derived: sum of 2 quarters · filed 2025-04-16 | $244.21K derived: sum of 3 quarters · filed 2025-04-16 | $257.72K 10-K/A · filed 2025-04-16 |
| 2023-09-30 | $80.78K 10-Q · filed 2024-11-14 | $161.56K derived: sum of 2 quarters · filed 2024-11-14 | $175.07K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $80.78K 10-Q · filed 2024-10-09 | $175.07K 10-Q · filed 2024-10-09 | ||
| 2023-03-31 | $80.78K 10-Q/A · filed 2024-10-09 |